key: cord-0882426-wbwtmsx0
authors: Morsli, M.; Anani, H.; Bréchard, L.; Delerce, J.; Bedotto, M.; Fournier, P.-E.; Drancourt, M.
title: LamPORE SARS-CoV-2 diagnosis and genotyping: a preliminary report
date: 2021-03-31
journal: J Clin Virol
DOI: 10.1016/j.jcv.2021.104815
sha: 5cc3888f888061055517c692f4df7260140bcaf1
doc_id: 882426
cord_uid: wbwtmsx0

nan

MM contributed to the experimental design, performance of the work, data analysis, interpretation and writing. AH collected samples, carried out data analysis and writing.

BL organized the work. DJ conducted bioinformatic data analysis. BM contributed to the experimental design. PEF and DM contributed to critically reviewing the manuscript, interpreting the data, coordinating and directing the work. All authors declare that they have read and approved the manuscript.

Only nasopharyngeal residual fluid left from standard-of-care clinical laboratory testing was used. All specimens had been referred to our laboratory for diagnostic purposes between 1 September and 1 November 2020. The study was approved by our Institute's Ethics Committee under number 2020-016603. LAMP amplification and library preparation were followed by library sequencing on the LamPORE instrument. A genotyping step was added to specifically detect SARS-COV-2 genotype 4.

SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): Diagnostic and proposed therapeutic options

The diagnosis of SARS-CoV2 pneumonia: A review of laboratory and radiological testing results

LamPORE: rapid, accurate and highly scalable molecular screening for SARS-CoV-2 infection, based on nanopore sequencing

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

Correlation between 3790 qPCR positives samples and positive cell